These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 17503896)
21. Approaches to drug therapy in older cancer patients. Einhorn LH Oncology (Williston Park); 1992 Feb; 6(2 Suppl):69-73. PubMed ID: 1532740 [TBL] [Abstract][Full Text] [Related]
22. Adherence and oral agents with older patients. Maloney KW; Kagan SH Semin Oncol Nurs; 2011 May; 27(2):154-60. PubMed ID: 21514484 [TBL] [Abstract][Full Text] [Related]
23. The use of oral cytotoxic and cytostatic drugs in cancer treatment. Sparreboom A; de Jonge MJ; Verweij J Eur J Cancer; 2002 Jan; 38(1):18-22. PubMed ID: 11750835 [TBL] [Abstract][Full Text] [Related]
24. Pharmacology of antineoplastic medications in older cancer patients. Balducci L Oncology (Williston Park); 2009 Jan; 23(1):78-85. PubMed ID: 19283925 [TBL] [Abstract][Full Text] [Related]
25. Recent developments in the pharmacology of anticancer drugs in the elderly. Lichtman SM Curr Opin Oncol; 1998 Nov; 10(6):572-9. PubMed ID: 9818238 [TBL] [Abstract][Full Text] [Related]
26. The role of diet on the clinical pharmacology of oral antineoplastic agents. Ruggiero A; Cefalo MG; Coccia P; Mastrangelo S; Maurizi P; Riccardi R Eur J Clin Pharmacol; 2012 Feb; 68(2):115-22. PubMed ID: 21796375 [TBL] [Abstract][Full Text] [Related]
27. Assessment and measurement of adherence to oral antineoplastic agents. Spoelstra SL; Given CW Semin Oncol Nurs; 2011 May; 27(2):116-32. PubMed ID: 21514481 [TBL] [Abstract][Full Text] [Related]
28. Oral delivery of anticancer drugs II: the prodrug strategy. Mazzaferro S; Bouchemal K; Ponchel G Drug Discov Today; 2013 Jan; 18(1-2):93-8. PubMed ID: 22960308 [TBL] [Abstract][Full Text] [Related]
30. The role of myelopoietic growth factors in managing cancer in the elderly. Balducci L; Carreca I Drugs; 2002; 62 Suppl 1():47-63. PubMed ID: 12479594 [TBL] [Abstract][Full Text] [Related]
32. Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer. Bonate PL; Cunningham CC; Gaynon P; Jeha S; Kadota R; Lam GN; Razzouk B; Rytting M; Steinherz P; Weitman S Cancer Chemother Pharmacol; 2011 Apr; 67(4):875-90. PubMed ID: 20582417 [TBL] [Abstract][Full Text] [Related]
33. Pharmacology of aging and cancer: how useful are pharmacokinetic tests? Lichtman SM Interdiscip Top Gerontol; 2013; 38():104-23. PubMed ID: 23503519 [TBL] [Abstract][Full Text] [Related]
34. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415. Adis International Ltd Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590 [TBL] [Abstract][Full Text] [Related]
35. Pharmacology of cancer chemotherapy in the older person. Baker SD; Grochow LB Clin Geriatr Med; 1997 Feb; 13(1):169-83. PubMed ID: 8995106 [TBL] [Abstract][Full Text] [Related]
36. Chemotherapy in the elderly. Lichtman SM Semin Oncol; 2004 Apr; 31(2):160-74. PubMed ID: 15112147 [TBL] [Abstract][Full Text] [Related]
37. Practical treatment guide for dose individualisation in cancer chemotherapy. Canal P; Chatelut E; Guichard S Drugs; 1998 Dec; 56(6):1019-38. PubMed ID: 9878990 [TBL] [Abstract][Full Text] [Related]